Paliperidone
Product Images NDC 49252-035

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 49252-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Inventia Healthcare Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

05e67b7a-0134-451c-b344-8d9adacbae59-1 (05e67b7a 0134 451c B344 8d9adacbae59 1)

This is a description of Paliperidone extended-release tablets. Each tablet contains 1.5mg of Paliperidone USP, and should be taken whole, once daily. The tablets should be stored at a controlled room temperature of 20°C to 25°C, and kept in a tight container to protect from moisture. The package insert should be consulted for prescribing information. The tablets come in a blister pack with 30 tablets, and the manufacturer is Inventia Healthcare Limited in India. The code at the bottom of the page includes a product classification code and details for printing a 2D barcode.*

FDA Label Image

05e67b7a-0134-451c-b344-8d9adacbae59-2 (05e67b7a 0134 451c B344 8d9adacbae59 2)

This is a medication label for Paliperidone, an extended-release tablet used to treat certain mental disorders such as schizophrenia. Each tablet contains 3 mg of Paliperidone and should be taken once daily. The tablets should not be divided, crushed, or chewed. The label includes dosage instructions, storage directions, and manufacturer information. It also cautions to keep the medication in a tight container and out of reach of children. The unvarnished area measures 45 x 15 mm.*

FDA Label Image

05e67b7a-0134-451c-b344-8d9adacbae59-3 (05e67b7a 0134 451c B344 8d9adacbae59 3)

This seems to be a description of a medication called "Paliperidone". It comes in a bottle with 30 tablets, each containing 6mg of the active ingredient. The tablets are extended-release and meant to be taken once a day, without dividing, crushing or chewing. The medication should be stored at room temperature and kept away from moisture in a tight container. The manufacturing details are also provided along with a code for internal identification. The rest of the text seems to be an incomplete outline of potential features and a product identifier.*

FDA Label Image

05e67b7a-0134-451c-b344-8d9adacbae59-4 (05e67b7a 0134 451c B344 8d9adacbae59 4)

This is a description of Paliperidone Extended-Release Tablets, each containing a dose of 9mg USP and comes in a pack of 30 tablets. It is advised to swallow the tablets whole without crushing, dividing, or chewing it. The tablets should be taken once a day. It should be stored at a temperature between 20°C to 26°C (68°F to 77°F), and protected from moisture. Paliperidone is used to treat schizophrenia and other mental illnesses. This medicine is manufactured by Inventia Healthcare Limited in India, and it is provided with a 2D barcode for product identification.*

FDA Label Image

05e67b7a-0134-451c-b344-8d9adacbae59-5 (05e67b7a 0134 451c B344 8d9adacbae59 5)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.